1. The Critical Importance of Statistical Test Selection
In clinical research, choosing an inappropriate statistical test is one of the quickest routes to manuscript rejection. Journal editors and peer reviewers look closely at the "Statistical Analysis" section of your methodology. When continuous data that violates normality assumptions is analyzed using a standard Student's t-test, or when paired before-after clinical readings are treated as independent observations with Chi-Square, the reported p-values, confidence intervals, and ultimate study conclusions become scientifically invalid.
Statistical test selection is not guesswork. It follows a rigorous 4-step logic based strictly on your study design, variable types, distribution normality, and number of comparison groups.
2. Step 1: Classify Your Primary Variables
Before running tests in SPSS, R, Stata, or GraphPad Prism, categorize every dependent (outcome) and independent (predictor) variable into one of three primary classifications:
Discrete groups with no natural order (e.g., Blood Group [A, B, AB, O], Gender [Male, Female], Cure Status [Cured, Relapsed]).
Categorical groups with ranked hierarchy, but non-uniform intervals (e.g., Cancer Stage [I, II, III, IV], Pain VAS Score [0–10], Likert survey).
Quantitative numeric measurements along an equal scale (e.g., SBP in mmHg, Serum Creatinine in mg/dL, Tumor Size in mm, Age in Years).
3. Step 2: Test for Normality (Parametric vs. Non-Parametric)
For continuous variables, determining whether the data follows a Gaussian (normal) bell curve dictates whether you use Parametric tests (reporting Mean ± Standard Deviation) or Non-Parametric tests (reporting Median and Interquartile Range [IQR]):
- Shapiro-Wilk Test: The gold-standard numerical test for normality when sample size is \(N < 50\). A \(p ext{-value} > 0.05\) indicates normal distribution.
- Kolmogorov-Smirnov (with Lilliefors correction): Preferred for larger sample cohorts (\(N > 100\)).
- Visual Inspection (Q-Q Plots & Histograms): Always evaluate Quantile-Quantile (Q-Q) plots alongside statistical tests. Skewness and kurtosis coefficients between \(-1.0\) and \(+1.0\) generally satisfy parametric robustness.
Clinical Pearl on Small Sample Sizes:
If your cohort has fewer than 30 patients per arm (\(N < 30\)) and displays noticeable skewness or outliers, always default to Non-Parametric tests. Non-parametric methods maintain high statistical power without risking false-positive alpha inflation.
4. Master Statistical Test Decision Matrix
Use this reference table to pinpoint the exact test required for your specific data structure:
| Research Objective | Variable Type | Parametric Test (Normal) | Non-Parametric Test (Skewed) |
|---|---|---|---|
| Compare 2 Independent Groups | Continuous | Independent Samples t-test | Mann-Whitney U (Wilcoxon Rank-Sum) |
| Compare 2 Paired / Repeated Points | Continuous | Paired Samples t-test | Wilcoxon Signed-Rank Test |
| Compare 3+ Independent Groups | Continuous | One-Way ANOVA (+ Tukey post-hoc) | Kruskal-Wallis Test (+ Dunn post-hoc) |
| Compare 3+ Repeated Measures | Continuous | Repeated Measures ANOVA | Friedman Test |
| Assess Categorical Association | Nominal (Categorical) | Chi-Square (χ²) Test of Independence | Fisher's Exact Test (if cell count < 5) |
| Correlate 2 Variables | Continuous / Ordinal | Pearson Correlation (r) | Spearman Rank Correlation (ρ) |
5. Multivariable Modeling: Controlling for Confounding
Univariable tests (like t-tests or Chi-square) demonstrate crude associations but cannot control for confounding factors like age, baseline disease severity, or comorbidities. In modern clinical research, multivariable regression is mandatory:
- Multiple Linear Regression: Used when the dependent outcome is Continuous (e.g., predicting exact post-op hospital stay duration in days).
- Binary Logistic Regression: Used when the dependent outcome is Dichotomous (e.g., 30-day Mortality: Yes vs No). Reports Adjusted Odds Ratios (aOR) with 95% Confidence Intervals.
- Cox Proportional Hazards Model: Used for Time-to-Event outcomes with censoring (e.g., Overall Survival in Oncology). Reports Hazard Ratios (HR).
Dr. Manjinder Singh Sidhu
MBBS, MD (Radiotherapy)
Senior Consultant in Radiation Oncology at DMCH Ludhiana with 18+ years experience, international fellowship at UCSD/Scripps USA, and 18 peer-reviewed publications.